×
About 11,195 results

ALLMedicine™ Heart Transplantation Center

Research & Reviews  4,199 results

Conduction system pacing vs biventricular pacing in patients with ventricular dysfuncti...
https://doi.org/10.1111/pace.14535
Pacing and Clinical Electrophysiology : PACE; Pujol-López M, Jiménez Arjona R et. al.

May 19th, 2022 - It is unknown whether His-Purkinje conduction system pacing (HPCSP), as either His bundle or left bundle branch pacing, could be an alternative to cardiac resynchronization therapy (BiVCRT) for patients with left ventricular dysfunction needing ve...

Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case rep...
https://doi.org/10.1007/s12350-022-02990-x 10.1186/1750-1172-8-31 10.1007/s00508-020-01781-z 10.1001/archneur.62.7.1057 10.7861/clinmedicine.18-2-s30 10.3949/ccjm.84.s3.02 10.1002/mus.26723 10.1093/ehjci/jeu107 10.3109/13506129.2014.967846 10.3109/13506129.2011.615872 10.1007/s12350-017-1166-7
Journal of Nuclear Cardiology : Official Publication of T... Ungericht M, Wanschitz J et. al.

May 18th, 2022 - We identified two patients with transthyretin (ATTR) amyloid myopathy (one ATTR variant amyloidosis, ATTRv; one wild-type ATTR amyloidosis, ATTRwt). Myopathy was the initial manifestation in ATTRwt, whereas it followed neuropathy and cardiomyopath...

Modulation of mitochondrial respiration during early reperfusion reduces cardiac injury...
https://doi.org/10.1097/FJC.0000000000001290
Journal of Cardiovascular Pharmacology; Akande O, Chen Q et. al.

May 18th, 2022 - Donation after circulatory death (DCD) donors are a potential source for heart transplantation. The DCD process has unavoidable ischemia and reperfusion (I/R) injury, primarily mediated through mitochondria, which limits routine utilization of hea...

You've got some nerve (after heart transplantation).
https://doi.org/10.1016/j.healun.2022.02.024
The Journal of Heart and Lung Transplantation : the Offic... Tchoukina I, Shah KB

May 18th, 2022 - You've got some nerve (after heart transplantation).|2022|Tchoukina I,Shah KB,|

Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyo...
https://doi.org/10.1016/j.healun.2022.03.020
The Journal of Heart and Lung Transplantation : the Offic... Boen HM, Loeys BL et. al.

May 18th, 2022 - The importance of genetic testing for cardiomyopathies has increased in the last decade. However, in heart transplant patients with former cardiomyopathy, genetic testing in retrospect is not routinely performed. We hypothesize that the yield of g...

see more →

Guidelines  3 results

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement ...
https://doi.org/10.1016/j.cjca.2019.12.025
The Canadian Journal of Cardiology; Chih S, McDonald M et. al.

Mar 9th, 2020 - Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evid...

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardiove...
https://doi.org/10.1016/j.cjca.2016.09.009
The Canadian Journal of Cardiology; Bennett M, Parkash R et. al.

Dec 31st, 2016 - Sudden cardiac death is a major public health issue in Canada. However, despite the overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in the prevention of cardiac death there remains significant variability...

The 2016 International Society for Heart Lung Transplantation listing criteria for hear...
https://doi.org/10.1016/j.healun.2015.10.023
The Journal of Heart and Lung Transplantation : the Offic... Mehra MR, Canter CE et. al.

Jan 19th, 2016 - The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.|2016|Mehra MR,Canter CE,Hannan MM,Semigran MJ,Uber PA,|standards,supply & distribution,

see more →

Drugs  5 results see all →

Clinicaltrials.gov  101 results

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)
https://clinicaltrials.gov/ct2/show/NCT05373108

May 13th, 2022 - Many patients with end-stage heart failure, a condition in which the heart fails to pump enough blood to support the body's other organs, are fortunate enough to receive a heart transplant. However, despite taking medicines aimed at blunting the i...

A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT03477383

May 2nd, 2022 - The primary objective is a comparison of an the established, invasive diagnostic test, the endomyocardial biopsy (EMB) against a new, non-invasive test. The new test is the measurement of donor-derived cell-free DNA (dd-cfDNA) circulating in the b...

IMPact of Donor Heart Function on Recipient Outcomes - a prospectiVE Study to Increase the Utilization of Donor HEARTs
https://clinicaltrials.gov/ct2/show/NCT04393181

May 2nd, 2022 - Severe heart failure is a diagnosis with a very poor prognosis where the 2-year mortality rate for serious heart failure is over 50%, which exceeds many cancer diagnoses. Despite advances in pharmacological treatment and mechanical pumps, heart tr...

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation
https://clinicaltrials.gov/ct2/show/NCT05309382

Apr 25th, 2022 - Subjects will undergo surveillance monitoring for rejection per the institution's standard clinical care schedule after transplant. Surveillance procedures may include EMB, imaging such as echocardiography, and/or molecular testing. Surveillance i...

Observational Study of the Clinical Use of the OCS™ Heart
https://clinicaltrials.gov/ct2/show/NCT03687723

Mar 28th, 2022 - This is an observational study at two centers that will enroll minimum of 60 heart transplant recipients transplanted with donor heart preserved using the OCS™ Heart System. All consented subjects who receive OCS™-preserved heart transplants will ...

see more →

News  170 results

FDA Warns of Pump Defect With Medtronic HVAD System
https://www.medscape.com/viewarticle/972954

Apr 29th, 2022 - Patients implanted with the Medtronic Heartware Ventricular Assist Device (HVAD) System who develop pump thrombosis could have a welding defect in the internal pump causing the pump to malfunction, the US Food and Drug Administration (FDA) says in...

Facial Follicular Spicules: A Rare Cutaneous Presentation of Trichodysplasia Spinulosa
https://www.mdedge.com/dermatology/article/254201/hair-nails/facial-follicular-spicules-rare-cutaneous-presentation
Joy F. King, MD, PhD, Adam C. Byrd, MD et. al.

Apr 28th, 2022 - To the Editor: A 57-year-old man with hypertension, dyslipidemia, and congestive heart failure presented with a disfiguring eruption comprised of asymptomatic papules on the face that appeared 12 months post–heart transplantation. Immunosuppressiv.

What Does a Pig-to-Human Heart Transplant Mean for Medicine?
https://www.medscape.com/viewarticle/966488

Jan 12th, 2022 - Scientific achievements usually raise big new questions, and the remarkable surgery that took place on January 7, when Maryland resident David Bennett was transplanted with a genetically modified heart from a pig, has been no different. The 57-yea...

A New Bicaval Valve Implant Could Improve Outcomes in Some Heart Transplant Patients
https://www.medscape.com/viewarticle/962835

Nov 15th, 2021 - NEW YORK (Reuters Health) - A new implanted bicaval valve (BCV) could improve tricuspid regurgitation in some heart-transplant patients with severe symptomatic tricuspid regurgitation, according to a new case report. Tricuspid regurgitation is the...

Heart Failure Clinical Practice Guidelines (ESC, 2021) 
https://www.medscape.com/viewarticle/958030

Sep 3rd, 2021 - Clinical practice guidelines on the management of heart failure by the European Society of Cardiology (ESC) were published in August 2021 in the European Heart Journal.[1] HFpEF (heart failure with preserved ejection fraction) diagnosis requires e...

see more →